Gao QP, Yang DZ, Yuan ZB, Guo YX. Prognostic factors and its predictive value in patients with metastatic spinal cancer. World J Clin Cases 2021; 9(20): 5470-5478 [PMID: 34307601 DOI: 10.12998/wjcc.v9.i20.5470]
Corresponding Author of This Article
Yu-Xia Guo, MD, Associate Chief Physician, Department of Gynecology, Shenzhen People’s Hospital, 2nd Clinical Medical College of Jinan University, No. 1017 Dongmen North Road, Luohu District, Shenzhen 518020, Guangdong Province, China. yxguomedicine@163.com
Research Domain of This Article
Orthopedics
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Qing-Peng Gao, Department of Spine Surgery, The Second Clinical Medical College of Jinan University, Shenzhen 518020, Guangdong Province, China
Da-Zhi Yang, Zheng-Bin Yuan, Department of Spine Surgery, Shenzhen People’s Hospital, 2nd Clinical Medical College of Jinan University, Shenzhen 518020, Guangdong Province, China
Yu-Xia Guo, Department of Gynecology, Shenzhen People’s Hospital, 2nd Clinical Medical College of Jinan University, Shenzhen 518020, Guangdong Province, China
Author contributions: Gao QP, Yang DZ, Yuan ZB, and Guo YX contributed to the writing and revising of the manuscript; and all authors proofed and confirmed the revised manuscript.
Institutional review board statement: The study was reviewed and approved by the Shenzhen People’s Hospital Institutional Review Board.
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: This is no conflict of interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yu-Xia Guo, MD, Associate Chief Physician, Department of Gynecology, Shenzhen People’s Hospital, 2nd Clinical Medical College of Jinan University, No. 1017 Dongmen North Road, Luohu District, Shenzhen 518020, Guangdong Province, China. yxguomedicine@163.com
Received: April 1, 2021 Peer-review started: April 1, 2021 First decision: April 13, 2021 Revised: April 25, 2021 Accepted: April 26, 2021 Article in press: April 26, 2021 Published online: July 16, 2021 Processing time: 96 Days and 23 Hours
Core Tip
Core Tip: Early detection and prompt management usually ensure a better prognosis for cancer patients. It is important to examine the prognostic factors that influence the prognosis of patients with metastatic spine tumors in order to determine the optimal treatment strategy. The present study showed that age, comorbidity of metastasis from elsewhere, therapies, number of spinal tumors, patient attitude toward tumors and Karnofsky performance score significantly influenced prognosis of patients with metastatic spine tumors. Moreover, Frankel spinal cord injury functional classification scale score, metastatic spinal cord compression, spinal instability neoplastic score and revised Tokuhashi score were important factors influencing the prognosis of this disease and the treatment selection.
